RegeneRx Biopharmaceuticals, Inc. Financial Ratios — RGRX

Profitability (USD)

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-146.27	-123.62	-114.03	-260.52	-228.85	-336.22	-555.21	-806.25	37.54	52.59	-784.69	-282.89	-241.13	-173.98	-207.24
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-0.39	-0.4	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	100	100	100	100	- -	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-6,393.46	- -	-591.19	-397.1	-62.09	-3,083.88	- -	-2,814.84	-1,790.51	-2,544.63	-1,895.61	-1,642.04	-1,686.46	-1,730.71	-1,826.44
Operating Margin (%)	-6,404.97	- -	-592.33	-397.7	-62.65	-3,100.84	- -	-2,820.46	-1,794.08	-2,550.01	-1,899.56	-1,643.89	-1,686.46	-1,730.71	-1,826.44
Incremental Operating Margin (%)	- -	-2,541.65	- -	- -	- -	- -	2,174.86	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-397.4	-63.08	-2,276.97	- -	-8,695.44	245.56	679.75	-2,861.55	-1,829.35	-1,984.56	-2,081.47	-2,250.43
Profit Margin (%)	-6,316.04	- -	-591.37	-397.4	-63.08	-2,276.97	- -	-8,695.44	245.56	505.7	-2,861.55	-1,829.35	-1,984.56	-2,081.47	-2,250.43
Net Income to Common Margin (%)	-6,316.04	- -	-591.37	-397.4	-63.08	-2,276.97	- -	-8,695.44	245.56	505.7	-2,861.55	-1,936.91	-1,984.56	-2,081.47	-2,250.43
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.61	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.55	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Total Debt	- -	- -	- -	- -	- -	- -	1	1	1	1	- -	1	1	1	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -	1	1	1	1
Total Debt/EBITDA	- -	- -	- -	- -	-0.33	-0.48	-0.37	-0.4	-0.49	-0.44	-0.04	-0.58	-0.79	-0.88	-1.03
Net Debt/EBITDA	0.53	0.67	0.75	0.02	-0.16	-0.47	0.18	-0.22	-0.03	-0.31	0.14	-0.05	-0.41	0.07	-0.77
Total Debt/EBIT	- -	- -	- -	- -	-0.33	-0.47	-0.36	-0.4	-0.49	-0.44	-0.04	-0.58	-0.79	-0.88	-1.03
Net Debt/EBIT	0.52	0.67	0.75	0.02	-0.16	-0.47	0.18	-0.22	-0.03	-0.31	0.14	-0.05	-0.41	0.07	-0.77
EBITDA to Interest Expense	- -	- -	- -	- -	-146.32	-9.01	-8.45	-9.87	-9.64	-8.44	-15.13	-8.22	-5.56	-4.09	-4.31
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-146.32	-9.01	-8.52	-9.87	-9.64	-8.44	-15.13	-8.22	-5.56	-4.09	-4.31
EBIT to Interest Expense	- -	- -	- -	- -	-147.65	-9.06	-8.48	-9.89	-9.66	-8.45	-15.16	-8.23	-5.56	-4.09	-4.31
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-1,316.22	-1,842.18	-2,115.67	-24,883.33	-27,002.79	-226,934.19	-10,504	-29,303.87	-12,145.02	-45,998.18	-37,629.29	-15,066.47	-19,710.2	-8,587.48	-29,325.06
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-0.29	-0.45	-0.57	-0.66	-0.49	-0.04	- -	-0.66	-0.88	-1.04	-1.27
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	77.28	1,012.27	59.63	192.3	59.37	19.3	- -	99.48	172.45	88.49	367.09
Total Debt/Equity (%)	- -	- -	- -	- -	-26.93	-26.68	-33.07	-10.22	-13.39	-15.42	-2.48	-31.41	-36.34	-52.24	-41.98
Total Debt/Capital (%)	- -	- -	- -	- -	-0.29	-0.45	-0.57	-0.66	-0.78	-0.61	-0.05	-0.69	-0.95	-1.07	-1.31
Total Debt/Total Assets (%)	- -	- -	- -	- -	77.28	1,012.27	59.63	192.3	94.16	279.58	19.48	103.28	185.98	90.66	378.44
Net Debt to Equity	-123.03	-117.62	-104.95	27.18	-13.07	-26.29	16.24	-5.51	-0.7	-11.01	8.25	-2.91	-18.76	4.24	-31.4
Net Debt/Capital (%)	6.76	4.91	4.07	0.12	-0.14	-0.44	0.28	-0.35	-0.04	-0.44	0.17	-0.06	-0.49	0.09	-0.98
EBITDA	-11	-6	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1
EBITDA-CapEx	-11	-6	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1
Operating Income (Loss)	-11	-7	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1

Liquidity (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Cash Ratio	4.27	4.95	6.15	0.14	0.2	0.01	2.06	0.88	1.17	0.08	0.75	2.64	1.07	2.86	0.53
Current Ratio	4.44	5.17	6.79	0.44	0.48	0.05	2.27	0.95	1.29	0.1	0.87	2.81	1.2	2.91	0.55
Quick Ratio	4.27	4.95	6.16	0.41	0.45	0.01	2.06	0.88	1.17	0.08	0.75	2.64	1.07	2.86	0.53
CFO/Avg Current Liab	-5.57	-5.58	-6.68	-7.59	-0.36	-1.18	-3.32	-1.37	-2.1	-0.47	-0.72	-4.08	-3.14	-2.39	-1.91
Common Equity/Total Assets	-1,316.22	-1,842.18	-2,115.67	-24,883.33	-27,002.79	-226,934.19	-10,504	-29,303.87	-12,145.02	-45,998.18	-37,629.29	-15,066.47	-19,710.2	-8,587.48	-29,325.06
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-0.29	-0.45	-0.57	-0.66	-0.49	-0.04	- -	-0.66	-0.88	-1.04	-1.27
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	77.28	1,012.27	59.63	192.3	59.37	19.3	- -	99.48	172.45	88.49	367.09
Total Debt/Equity (%)	- -	- -	- -	- -	-26.93	-26.68	-33.07	-10.22	-13.39	-15.42	-2.48	-31.41	-36.34	-52.24	-41.98
Total Debt/Capital (%)	- -	- -	- -	- -	-0.29	-0.45	-0.57	-0.66	-0.78	-0.61	-0.05	-0.69	-0.95	-1.07	-1.31
Total Debt/Total Assets (%)	- -	- -	- -	- -	77.28	1,012.27	59.63	192.3	94.16	279.58	19.48	103.28	185.98	90.66	378.44
CFO/Total Liabilities	-797.22	-698.73	-810.34	-668.59	-19.87	-46.97	-64.04	-7.4	-15.42	-15.27	-35.63	-37.29	-29.83	-28.17	-24.58
CFO/CapEx	- -	- -	-190.84	-4,999.99	- -	- -	-127.92	-488.23	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	3.72	-8.66	-17.71	-389.56	-380.44	-3,264.49	-148.93	-422.51	-173.3	-673.1	-538.41	-212.59	-273.17	-119.18	-420.63

Working Capital (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Accounts Receivable Turnover	12.5	- -	158.75	13.43	6.85	0.33	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	29.21	- -	2.3	27.18	53.25	1,097.76	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Market Capitalization	60	31	15	11	7	4	13	45	34	18	19	18	59	22	20
- Cash & Cash Equivalents	6	4	4	- -	- -	- -	1	- -	1	- -	- -	1	- -	1	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	1	1	1	1	- -	1	1	1	1
Enterprise Value	54	26	11	11	7	5	13	45	34	19	19	18	60	22	21
Total Capital	-78	-84	-89	-95	-96	-97	-99	-104	-104	-104	-106	-107	-108	-109	-111
Total Debt/Capital (%)	- -	- -	- -	- -	-0.29	-0.45	-0.57	-0.66	-0.78	-0.61	-0.05	-0.69	-0.95	-1.07	-1.31
Total Debt / EV	- -	- -	- -	- -	0.04	0.09	0.04	0.02	0.02	0.03	- -	0.04	0.02	0.05	0.07
EV/Sales	323.53	- -	13.26	7.35	5.51	162.77	- -	743.14	363.59	330.41	265.96	240.11	780.89	288.01	274.81
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	60	31	15	11	7	4	13	45	40	21	19	18	59	22	20
Diluted Enterprise Value	54	26	11	11	7	5	13	45	40	21	19	18	60	22	21
EV per Share	106.9	47.18	16.46	13.86	9.06	5.87	14.1	44.37	31.77	17.42	15.35	14.07	44.95	15.95	14.69
TTM Sales	- -	- -	1	2	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-11	-6	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1
TTM Operating Income	-11	-7	-5	-6	-1	-1	-2	-2	-2	-1	-1	-1	-1	-1	-1
TTM Cash Flow to Firm	- -	- -	- -	-5	- -	-1	-2	- -	-1	-1	-1	-1	-1	-1	-1
TTM Free Cash Flow to Firm	- -	- -	- -	-5	- -	-1	-2	- -	-1	-1	-1	-1	-1	-1	-1

Multiples (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Price/Free Cash Flow	-5.69	-4.98	-3.03	-2.07	-26.5	-5.59	-7.94	-85.21	-37.41	-31	-21.06	-16.11	-58.94	-22.39	-21.2
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	54	26	11	11	7	5	13	45	34	19	19	18	60	22	21
Low Price	64	31	19.5	7	6.66	4.25	5	13.01	25	13.9	8.75	7	14	14.5	10
EV/Sales	323.53	- -	13.26	7.35	5.51	162.77	- -	743.14	363.59	330.41	265.96	240.11	780.89	288.01	274.81
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	147.88	63.76	- -	- -	- -	- -	- -
Price/Earnings Average	-5.72	-5.8	-5.3	-2.86	-13.74	-9.4	-5.66	-7.04	206.01	106.15	-11.86	-14.4	-32.65	-25.72	-14.82
Price/Earnings High	-9.49	-16.72	-10.76	-4.27	-23.13	-14.37	-9.64	-11.56	349.55	142.51	-18.47	-30.83	-65.66	-71.13	-24.93
Price/Earnings Low	-3.07	-2.66	-2.66	-0.93	-6.42	-5.17	-1.69	-2.51	116.52	52.13	-5.3	-6.17	-12.26	-12.58	-8.31
Price/Book Value	-0.77	-0.36	-0.17	-0.12	-0.08	-0.05	-0.13	-0.43	-0.32	-0.17	-0.18	-0.17	-0.55	-0.2	-0.18
Price/Book Value Average	-0.78	-0.45	-0.3	-0.18	-0.12	-0.07	-0.16	-0.35	-0.45	-0.29	-0.22	-0.2	-0.46	-0.37	-0.23
Price/Book Value High	-1.29	-1.29	-0.6	-0.27	-0.2	-0.1	-0.27	-0.58	-0.76	-0.39	-0.35	-0.43	-0.92	-1.03	-0.38
Price/Book Value Low	-0.42	-0.2	-0.15	-0.06	-0.06	-0.04	-0.05	-0.13	-0.25	-0.14	-0.1	-0.09	-0.17	-0.18	-0.13
Price/Tangible Book Value	13.08	8.27	4.17	-26.27	-7.1	-2.7	-7.84	-6.63	-5.59	-4.44	-8.46	-7.84	-21.01	-9.94	-5.79
Price/Tangible Book Value Average	13.24	10.17	7.37	-40.24	-11.37	-3.89	-9.11	-5.51	-7.78	-7.39	-10.69	-9.15	-17.61	-18.43	-7.43
Price/Tangible Book Value High	21.95	29.32	14.97	-60.05	-19.14	-5.95	-15.52	-9.03	-13.2	-9.92	-16.64	-19.59	-35.42	-50.97	-12.5
Price/Tangible Book Value Low	7.1	4.66	3.7	-13.13	-5.31	-2.14	-2.72	-1.96	-4.4	-3.63	-4.78	-3.92	-6.61	-9.01	-4.17
Price/Sales	357.11	- -	17.72	7.42	5.41	148.31	- -	737.02	363.14	322.41	268.58	238.87	773.1	288.88	259.75
Price/Sales Average	361.25	- -	31.31	11.37	8.67	214.1	- -	612.5	505.87	536.79	339.37	278.82	648.03	535.3	333.58
Price/Sales High	599.22	- -	63.65	16.96	14.59	327.11	- -	1,005.02	858.34	720.69	528.49	597.17	1,302.98	1,480.52	561.03
Price/Sales Low	193.69	- -	15.71	3.71	4.05	117.82	- -	217.92	286.11	263.62	151.62	119.43	243.22	261.8	187.01
Price/Cash Flow	-5.69	-4.98	-3.01	-2.07	-26.5	-5.59	-7.88	-85.03	-31.72	-27.55	-21.06	-16.11	-58.94	-22.39	-21.2
Price/Cash Flow Average	-5.76	-6.12	-5.32	-3.17	-42.45	-8.08	-9.15	-70.67	-44.19	-45.86	-26.62	-18.81	-49.4	-41.49	-27.22
Price/Cash Flow High	-9.55	-17.65	-10.82	-4.73	-71.45	-12.34	-15.59	-115.96	-74.98	-61.57	-41.45	-40.28	-99.33	-114.76	-45.78
Price/Cash Flow Low	-3.09	-2.81	-2.67	-1.03	-19.83	-4.44	-2.73	-25.14	-24.99	-22.52	-11.89	-8.06	-18.54	-20.29	-15.26
Price/Free Cash Flow Average	-5.76	-6.12	-5.35	-3.17	-42.45	-8.08	-9.22	-70.81	-52.11	-51.62	-26.62	-18.81	-49.4	-41.49	-27.22
Price/Free Cash Flow High	-9.55	-17.65	-10.88	-4.73	-71.45	-12.34	-15.71	-116.19	-88.42	-69.3	-41.45	-40.28	-99.33	-114.76	-45.78
Price/Free Cash Flow Low	-3.09	-2.81	-2.69	-1.04	-19.83	-4.44	-2.76	-25.19	-29.47	-25.35	-11.89	-8.06	-18.54	-20.29	-15.26
EV/Sales Average	327.67	- -	26.85	11.29	8.77	228.56	- -	618.62	506.33	544.79	336.75	280.06	655.83	534.43	348.64
EV/Sales High	565.64	- -	59.19	16.89	14.69	341.57	- -	1,011.15	858.8	728.68	525.87	598.41	1,310.77	1,479.65	576.08
EV/Sales Low	160.11	- -	11.25	3.63	4.15	132.27	- -	224.05	286.57	271.62	149	120.67	251.02	260.93	202.06
EV/EBITDA Average	-5.13	-5.13	-4.54	-2.84	-14.12	-7.41	-9.88	-21.98	-28.28	-21.41	-17.76	-17.06	-38.89	-30.88	-19.09
EV/EBITDA High	-8.85	-16.06	-10.01	-4.25	-23.66	-11.08	-16.95	-35.92	-47.96	-28.64	-27.74	-36.44	-77.72	-85.49	-31.54
EV/EBITDA Low	-2.5	-1.99	-1.9	-0.92	-6.68	-4.29	-2.83	-7.96	-16	-10.67	-7.86	-7.35	-14.88	-15.08	-11.06
EV/EBIT Average	-5.12	-5.12	-4.53	-2.84	-13.99	-7.37	-9.84	-21.93	-28.22	-21.36	-17.73	-17.04	-38.89	-30.88	-19.09
EV/EBIT High	-8.83	-16.02	-9.99	-4.25	-23.44	-11.02	-16.9	-35.85	-47.87	-28.58	-27.68	-36.4	-77.72	-85.49	-31.54
EV/EBIT Low	-2.5	-1.98	-1.9	-0.91	-6.62	-4.27	-2.82	-7.94	-15.97	-10.65	-7.84	-7.34	-14.88	-15.08	-11.06
Last Price	118	55	22	14	8.9	5.35	14.4	44	31.73	17	15.5	14	44.5	16	13.89
High Price	198	195	79	32	24	11.8	28.5	60	75	38	30.5	35	75	82	30
Enterprise Value Average	55	33	23	17	12	7	15	37	47	31	23	21	50	41	27
Enterprise Value High	95	104	50	26	20	10	26	61	80	41	37	46	101	114	44
Enterprise Value Low	27	13	10	5	6	4	4	14	27	15	10	9	19	20	16

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Shares Outstanding	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Diluted Weighted Avg Shares	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Basic Weighted Avg Shares	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Revenue per Share	0.33	- -	1.24	1.89	1.65	0.04	- -	0.06	0.09	0.05	0.06	0.06	0.06	0.06	0.05
EBITDA per Share	-21.13	-11.66	-7.34	-7.49	-1.02	-1.11	-1.66	-1.68	-1.56	-1.34	-1.09	-0.96	-0.97	-0.96	-0.98
Operating Income per Share	-21.16	-11.69	-7.35	-7.5	-1.03	-1.12	-1.67	-1.68	-1.57	-1.34	-1.1	-0.96	-0.97	-0.96	-0.98
Basic EPS, GAAP	-20.87	-11.66	-7.34	-7.5	-1.04	-0.82	-2.95	-5.19	0.21	0.27	-1.65	-1.14	-1.14	-1.15	-1.2
Basic EPS from Cont Ops	-20.87	-11.66	-7.34	-7.5	-1.04	-0.82	-2.95	-5.19	0.21	0.27	-1.65	-1.07	-1.14	-1.15	-1.2
Diluted EPS, GAAP	-20.87	-11.66	-7.34	-7.5	-1.04	-0.82	-2.95	-5.19	0.18	0.24	-1.65	-1.14	-1.14	-1.15	-1.2
Diluted EPS from Cont Ops	-20.87	-11.66	-7.34	-7.5	-1.04	-0.82	-2.95	-5.19	0.18	0.24	-1.65	-1.07	-1.14	-1.15	-1.2
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-20.74	-11.05	-7.3	-6.76	-0.34	-0.96	-1.83	-0.52	-1	-0.62	-0.74	-0.87	-0.76	-0.71	-0.66
Free Cash Flow per Basic Share	-20.74	-11.05	-7.34	-6.76	-0.34	-0.96	-1.84	-0.52	-1	-0.62	-0.74	-0.87	-0.76	-0.71	-0.66
Cash & Equivalents per Share	11.1	7.82	5.54	0.14	0.17	0.01	0.91	0.31	0.72	0.17	0.2	0.49	0.32	0.89	0.2
Book Value per Share	-152.95	-151.65	-130.69	-119.11	-117.97	-118.64	-106.99	-103.39	-98.08	-97.21	-87.6	-81.88	-81.55	-79.62	-78.07
Tangible Book Value per Share	9.02	6.65	5.28	-0.53	-1.25	-1.98	-1.84	-6.64	-5.68	-3.83	-1.83	-1.79	-2.12	-1.61	-2.4

RegeneRx Biopharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)